Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:RTQ1
Stock Latest News
Company Announcements
Avacta Raises £12.5m to Extend Runway and Advance Oncology Pipeline
2d ago
Premium
Company Announcements
Avacta launches £12.5m share placing to fund oncology pipeline and extend cash runway
2d ago
Premium
Company Announcements
Avacta Enters AIM Capital Access Window for Equity Raise After AVA6103 Milestone
8d ago
Premium
Company Announcements
Avacta strengthens finances as pre|CISION cancer pipeline gains clinical momentum
8d ago
Premium
Company Announcements
Avacta’s pre|CISION Platform Wins UK Pharma R&D Award as AVA6103 Advances in Oncology Trials
13d ago
Premium
Company Announcements
Avacta’s AVA6103 Trial Data Boost Confidence in Next-Gen Pancreatic Cancer Therapy
13d ago
Premium
Company Announcements
Avacta’s AVA6103 Hits Clinical Proof of Mechanism, Outperforms Enhertu in Preclinical Study
22d ago
Premium
Company Announcements
Avacta strengthens board with new audit chair amid oncology push
24d ago
Premium
Company Announcements
Avacta Cuts Convertible Bond Balance with Accelerated Cash Repayment
1M ago
Premium
Company Announcements
Avacta awards management share options tied to oncology pipeline milestones
1M ago
Premium
Company Announcements
Avacta Cuts Convertible Bond Principal with Accelerated Cash Repayment
3M ago
Premium
Company Announcements
Avacta Strengthens Board With Appointment of Patrick Vink as Deputy Chairman
3M ago
Premium
Company Announcements
Avacta Data Underscore Broad Potential of pre|CISION Cancer Platform
3M ago
Premium
Company Announcements
Avacta Wins FDA Backing for Single Pivotal Trial of AVA6000 in Salivary Gland Cancer
3M ago
Premium
Company Announcements
Avacta Wins Strong Shareholder Backing as All AGM Resolutions Pass
4M ago
Premium
Company Announcements
Avacta Extends Cash Runway as pre|CISION Oncology Pipeline Advances
4M ago
Premium
Company Announcements
Avacta Raises £9m to Cut Convertible Debt and Fund Oncology Pipeline
4M ago
Premium
Company Announcements
Avacta applies for AIM block listing to cover employee share options
4M ago
Premium
Company Announcements
Avacta Reports Strong Early Efficacy and Cardiac Safety for AVA6000 in Salivary Gland Cancer
4M ago
Premium
Company Announcements
Avacta reshapes board leadership as oncology pipeline advances
4M ago
Premium
Company Announcements
Avacta publishes 2025 annual report and sets June AGM with online business update
4M ago
Premium
Company Announcements
Avacta Earnings Call: Clinical Progress Amid Funding Risks
4M ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.